Nivolumab in Combination With Ipilimumab in Patients With Metastatic Renal Cell Carcinoma
Clinical trial NCT03297593 · COMPLETED
Trial details
- NCT number
- NCT03297593
- Sponsor
- Swiss Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-13
- Primary completion
- 2019-07-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.